R Gray
Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel
Hadji P, Gnant M, Gray R, Harbeck N, Thürlimann B, Untch M, Cortes J, Martin M, Albert U, Conte P, Ejlertsen B, Bergh J, Kaufmann M, Smith I, Dodwell D, Coleman R, Wilson C, Powles T, Clézardin P, Aapro M, Costa L, Body J, Markopoulos C, Santini D, Diel I, Di Leo A, Cameron D, Holen I. Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel. Ann Oncol 2015
Dec 17, 2015Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel
Dec 17, 2015Ann Oncol 2015
Hadji P, Gnant M, Gray R, Harbeck N, Thürlimann Beat, Untch M, Cortes J, Martin M, Albert U-S, Conte P-F, Ejlertsen B, Bergh J, Kaufmann M, Smith I, Dodwell D, Coleman R E, Wilson C, Powles T J, Clézardin P, Aapro M, Costa L, Body J-J, Markopoulos C, Santini D, Diel I, Di Leo A, Cameron D, Holen I
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Kaufmann M, Kilburn L, Perrone F, Rea D, Thürlimann B, van de Velde C, Pan H, Peto R, Davies C, Gnant M, Dubsky P, Cuzick J, Dowsett M, Forbes J, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes R, Gray R. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 2015; 386:1341-52.
Jul 23, 2015Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Jul 23, 2015Lancet 2015; 386:1341-52
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Kaufmann M, Kilburn L, Perrone F, Rea D, Thürlimann Beat, van de Velde C, Pan H, Peto R, Davies C, Gnant M, Dubsky P, Cuzick J, Dowsett M, Forbes J F, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes R C, Gray R